secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001628280-25-050671
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences cuts 70% of workforce (~31 employees) as part of strategic review
--------------------------------------------------------------------------------

- Workforce reduction of ~31 employees (approx. 70% of total staff) announced on Nov 6, 2025.
- Estimated cash expenditures of ~$6.0M for severance and benefits, majority recognized in Q4 2025.
- Restructuring linked to previously announced evaluation of strategic alternatives for the company.
- Company may incur additional costs; will amend filing if material changes arise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000162828025050671/0001628280-25-050671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000162828025050671/kzr-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer